Marius Nacht: "I won’t have another success in high-tech like Check Point, but in biotech I will"
25.04.22|Meir Orbach and Diana Bahur Nir
Marius Nacht is one of the founding fathers of Israeli cybersecurity, but in recent years he has preferred to invest in biotech. In an exclusive interview with Calcalist, he tells how his interest in the life sciences arose, why it’s important to make long-term investments in Israeli companies, and why he left the digital bank and parted ways with the aMoon fund
